Maricar Malinis, MD
Infectious Disease · Nashville, TNNPI 1619005055
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $12,685 of the $13,537 with a category attached, or 93.7%. 4 manufacturers reported payments, led by Takeda Pharmaceuticals U.S.A., Inc. at 38.8% of the total. Reporting peaked in 2023 at $9,499 and has fallen 98.5% since, to $138 in 2025. Among infectious disease clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 10 payments — averaging $1353.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$5K
- Modernatx, Inc.$4K
- Argenx US, Inc.$4K
- Sanofi$138
Across 58 payments — averaging $5393.95 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$212K
- Shire North American Group Inc$63K
- Astellas Pharma Global Development$37K
What the payments were for
- Consulting fees$12,68594%
- Travel & lodging$6245%
- Food & beverage$2292%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $5,250 |
| Modernatx, Inc. | 6 | $4,249 |
| Argenx US, Inc. | 1 | $3,900 |
| Sanofi | 1 | $138 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Moderna Covid-19 Vaccine$4,159
- VYVGART HYTRULO$3,900
- THYMOGLOBULIN$138
How this compares
$13,537 in reported general payments places this provider in the 90th percentile of 156 infectious disease providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other infectious disease in Nashville
- John KoetheNashville$91K
- Elizabeth PhillipsNashville$71K
- Kassem BourgiNashville$34K
- Celestine WanjallaNashville$24K
- Sean KellyNashville$17K
- David AronoffNashville$17K
- William SchaffnerNashville$16K
- Juli HortonNashville$14K
- Paul BryantNashville$12K
- Christina FiskeNashville$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.